The Indian pharmaceutical industry has been witness to significant changes over the past two years. The COVID-19 pandemic has greatly heightened the awareness for healthcare and medication. This awareness resulted in huge demand for the traditional allopathic medicines and there was a time when the retail medicine market was unable to cope up with it.
Then there was emergence of many substitute drugs that had a different name but similar chemical composition. But, any medicine can only be brought in into the domestic market only after successful clinical trials. Multiple organizations are involved in the process of executing successful clinical trials of new medicines throughout the country and the competition in this sector has also grown recently.
Orion Research from Pune was established back in 2017 considering an end-to-end service portfolio that would not only serve their clients, but also the patients that have put trust on them. The company brings extensive amount of experience and expertise to the table and have been providing premium services to various Pharmaceutical, Biotechnology, Medical Device companies as well as CROs. “Our multidisciplinary team is qualified to deliver clean and reliable data
by tracing key performance indicators through the life cycle of the project and constantly assessing risks,” states Dr. Manoj Singh, Co-founder, Orion Research.
Operational Excellence
There is a step by step module that Orion Research follows when it comes to executing clinical trials of new medicines. There is a prevailing problem in India relating the clinical trials of various new medicines that are coming into the market. Each and every drug is supposed to be tested on universal merit and there have been growing side effects in trial patients recently. This is why Orion thinks of the overall value addition and maintains healthy relations with all the patients that are putting their trust on it. Right from getting the complete medical records of patients till after the end of dosage or treatment, the company keeps in touch with them to monitor their health conditions regularly until there is no further threat involved.
There are specialized areas in which Orion can show the most productivity in. There are specific medical segments on which the company had performed more than 100 drug trails and have been associated with various similar projects throughout the country. “We take a few things very seriously such as patient consent, patient review and health monitoring that is included under our protocol and also follows the guidelines that are managed and regulated by government departments. Of the few areas that we have worked on until now, Medicine, Dermatology, Surgery, Oncology, Pulmonary Medicine etc. are few of the areas that we have spent most of our experience and expertise on”, mentions Dr. Singh.
Our multidisciplinary team is qualified to deliver clean and reliable data by tracing key performance indicators through the life cycle of the project and constantly assessing risks.
Roadmap Ahead
Being operational since 2017, Orion Research is a young but enthusiastic company. In a very short period of time, it has been able to understand the demands in the market and capture significant business in it in its area of operations. Being a part of a highly competitive market, it provides a very transparent view to its operations in a gain complete trust of the client. “In the coming years, we would like to grow more good will in the market and become one of the most trusted management and contract organizations in this segment”, concludes Dr. Singh.
We use cookies to ensure you get the best experience on our website. Read more...
